Vistra: Cogentrix And Meta Can Offset A Softer ERCOT Outlook (NYSE:VST)

seekingalpha.com · 2026-09-10

Vistra (VST) stays a Buy: Q2 EBITDA +30%, diversified generation, Cogentrix & Meta deals, and data-center demand support upside despite leverage—read now.

TickrTrends take: Vistra's ability to leverage Cogentrix and Meta contracts to counterbalance weakness in the ERCOT market highlights the company's diversified revenue streams, which supports TickrTrends' undervalued assessment for this Utilities sector operator. A valuation-focused reader should monitor whether these non-ERCOT revenue sources can consistently deliver the earnings growth needed to justify expansion of the company's current valuation multiple. The success of this diversification strategy will be key to determining if the undervalued positioning has room to close as market conditions evolve.

Read the full story at seekingalpha.com →